Published on 5 Mar 2024 on Insider Monkey via Yahoo Finance
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript March 4, 2024
Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.57. CARA isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Thank you for standing by, and welcome to Cara Therapeutics Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the call over to Matt Murphy, Manager of Investor Relations. Please go ahead.